Global Budesonide Capsules 麻豆原创 Research Report 2024

Publication ID:

PB501243186

Publication Date:

January 2, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Budesonide is a first-line anti-inflammatory agent and locally acting glucocorticosteroid indicated for the induction and maintenance of remission of mild to moderate ileocaecal Crohn's disease (capsules) and ulcerative colitis (enemas) as well as for the remission of active microscopic colitis (capsules).
The global Budesonide Capsules market was valued at US$ 902.3 million in 2023 and is anticipated to reach US$ 1646.3 million by 2030, witnessing a CAGR of 9.1% during the forecast period 2024-2030.
North American market for Budesonide Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Budesonide Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Budesonide Capsules include Perrigo, Mylan, Tillotts Pharma, Teva, Zydus Pharmaceuticals, Amneal, Mayne Pharma and Sciecure Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Budesonide Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Budesonide Capsules.
Report Scope
The Budesonide Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Budesonide Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Budesonide Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Perrigo
Mylan
Tillotts Pharma
Teva
Zydus Pharmaceuticals
Amneal
Mayne Pharma
Sciecure Pharma
Segment by Type
1mg
2mg
3mg
Segment by Application
Crohn's Disease
Collagenous Colitis
Autoimmune Hepatitis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Budesonide Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Budesonide Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Budesonide Capsules 麻豆原创 Overview
1.1 Product Overview and Scope of Budesonide Capsules
1.2 Budesonide Capsules Segment by Type
1.2.1 Global Budesonide Capsules 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 1mg
1.2.3 2mg
1.2.4 3mg
1.3 Budesonide Capsules Segment by Application
1.3.1 Global Budesonide Capsules 麻豆原创 Value by Application: (2024-2030)
1.3.2 Crohn's Disease
1.3.3 Collagenous Colitis
1.3.4 Autoimmune Hepatitis
1.4 Global Budesonide Capsules 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Budesonide Capsules Revenue 2019-2030
1.4.2 Global Budesonide Capsules Sales 2019-2030
1.4.3 Global Budesonide Capsules 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Budesonide Capsules 麻豆原创 Competition by Manufacturers
2.1 Global Budesonide Capsules Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Budesonide Capsules Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Budesonide Capsules Average Price by Manufacturers (2019-2024)
2.4 Global Budesonide Capsules Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Budesonide Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Budesonide Capsules, Product Type & Application
2.7 Budesonide Capsules 麻豆原创 Competitive Situation and Trends
2.7.1 Budesonide Capsules 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Budesonide Capsules Players 麻豆原创 Share by Revenue
2.7.3 Global Budesonide Capsules 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Budesonide Capsules Retrospective 麻豆原创 Scenario by Region
3.1 Global Budesonide Capsules 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Budesonide Capsules Global Budesonide Capsules Sales by Region: 2019-2030
3.2.1 Global Budesonide Capsules Sales by Region: 2019-2024
3.2.2 Global Budesonide Capsules Sales by Region: 2025-2030
3.3 Global Budesonide Capsules Global Budesonide Capsules Revenue by Region: 2019-2030
3.3.1 Global Budesonide Capsules Revenue by Region: 2019-2024
3.3.2 Global Budesonide Capsules Revenue by Region: 2025-2030
3.4 North America Budesonide Capsules 麻豆原创 Facts & Figures by Country
3.4.1 North America Budesonide Capsules 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Budesonide Capsules Sales by Country (2019-2030)
3.4.3 North America Budesonide Capsules Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Budesonide Capsules 麻豆原创 Facts & Figures by Country
3.5.1 Europe Budesonide Capsules 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Budesonide Capsules Sales by Country (2019-2030)
3.5.3 Europe Budesonide Capsules Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Budesonide Capsules 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Budesonide Capsules 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Budesonide Capsules Sales by Country (2019-2030)
3.6.3 Asia Pacific Budesonide Capsules Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Budesonide Capsules 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Budesonide Capsules 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Budesonide Capsules Sales by Country (2019-2030)
3.7.3 Latin America Budesonide Capsules Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Budesonide Capsules 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Budesonide Capsules 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Budesonide Capsules Sales by Country (2019-2030)
3.8.3 Middle East and Africa Budesonide Capsules Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Budesonide Capsules Sales by Type (2019-2030)
4.1.1 Global Budesonide Capsules Sales by Type (2019-2024)
4.1.2 Global Budesonide Capsules Sales by Type (2025-2030)
4.1.3 Global Budesonide Capsules Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Budesonide Capsules Revenue by Type (2019-2030)
4.2.1 Global Budesonide Capsules Revenue by Type (2019-2024)
4.2.2 Global Budesonide Capsules Revenue by Type (2025-2030)
4.2.3 Global Budesonide Capsules Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Budesonide Capsules Price by Type (2019-2030)
5 Segment by Application
5.1 Global Budesonide Capsules Sales by Application (2019-2030)
5.1.1 Global Budesonide Capsules Sales by Application (2019-2024)
5.1.2 Global Budesonide Capsules Sales by Application (2025-2030)
5.1.3 Global Budesonide Capsules Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Budesonide Capsules Revenue by Application (2019-2030)
5.2.1 Global Budesonide Capsules Revenue by Application (2019-2024)
5.2.2 Global Budesonide Capsules Revenue by Application (2025-2030)
5.2.3 Global Budesonide Capsules Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Budesonide Capsules Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Perrigo
6.1.1 Perrigo Corporation Information
6.1.2 Perrigo Description and Business Overview
6.1.3 Perrigo Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Perrigo Budesonide Capsules Product Portfolio
6.1.5 Perrigo Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Budesonide Capsules Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Tillotts Pharma
6.3.1 Tillotts Pharma Corporation Information
6.3.2 Tillotts Pharma Description and Business Overview
6.3.3 Tillotts Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Tillotts Pharma Budesonide Capsules Product Portfolio
6.3.5 Tillotts Pharma Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Budesonide Capsules Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Zydus Pharmaceuticals
6.5.1 Zydus Pharmaceuticals Corporation Information
6.5.2 Zydus Pharmaceuticals Description and Business Overview
6.5.3 Zydus Pharmaceuticals Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zydus Pharmaceuticals Budesonide Capsules Product Portfolio
6.5.5 Zydus Pharmaceuticals Recent Developments/Updates
6.6 Amneal
6.6.1 Amneal Corporation Information
6.6.2 Amneal Description and Business Overview
6.6.3 Amneal Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Amneal Budesonide Capsules Product Portfolio
6.6.5 Amneal Recent Developments/Updates
6.7 Mayne Pharma
6.6.1 Mayne Pharma Corporation Information
6.6.2 Mayne Pharma Description and Business Overview
6.6.3 Mayne Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mayne Pharma Budesonide Capsules Product Portfolio
6.7.5 Mayne Pharma Recent Developments/Updates
6.8 Sciecure Pharma
6.8.1 Sciecure Pharma Corporation Information
6.8.2 Sciecure Pharma Description and Business Overview
6.8.3 Sciecure Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sciecure Pharma Budesonide Capsules Product Portfolio
6.8.5 Sciecure Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Budesonide Capsules Industry Chain Analysis
7.2 Budesonide Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Budesonide Capsules Production Mode & Process
7.4 Budesonide Capsules Sales and 麻豆原创ing
7.4.1 Budesonide Capsules Sales Channels
7.4.2 Budesonide Capsules Distributors
7.5 Budesonide Capsules Customers
8 Budesonide Capsules 麻豆原创 Dynamics
8.1 Budesonide Capsules Industry Trends
8.2 Budesonide Capsules 麻豆原创 Drivers
8.3 Budesonide Capsules 麻豆原创 Challenges
8.4 Budesonide Capsules 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Perrigo
Mylan
Tillotts Pharma
Teva
Zydus Pharmaceuticals
Amneal
Mayne Pharma
Sciecure Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.